Clinical Trial

Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated April 21, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study sought to investigate whether modulation of cortical excitability of the gluteal musculature, via tDCS paired with exercise, will reduce the amount the knee caves in during functional tasks in individuals with PFP. The objective is the explore if having tDCS target the area of the brain controlling hip muscles, when paired with exercise, will be more effective in reducing the amount the knee caves in for individuals with PFP versus those who receive exercise alone as their treatment. The aim is to contribute our findings to the growing knowledge in this area in order to help establish the possibility, and feasibility, of its use in clinical settings to strengthen traditional treatments for this patient population.
Trial Details
NCT Number NCT06565520
Lead Sponsor University of Nevada, Las Vegas
Conditions Patellofemoral Pain Syndrome
Enrollment 50 participants
Start Date 2024-04-24
Primary Completion 2025-04-21 (estimated)
Study Completion 2025-04-21 (estimated)
Updated on ClinicalTrials.gov 2024-08-22